Immunotherapy-treated melanoma brain metastases within the French national cohort, MelBase.

C. Allayous,S. Dalle,Jean-Philippe Lacour,L. Mortier,C. Dutriaux,P. Saiag,S. Dalac,F. Aubin,E. Maubec,Marie Beylot-Barry,T. Lesimple,J.-P. Arnault,Julie de Quatrebarbes,P.-E. Stoebner,Brigitte Dreno,I. Chami,Raphaël Porcher,A. Kowal,Marie Thérèse Leccia,Celeste Lebbe

Immunotherapy-treated melanoma brain metastases within the French national cohort, MelBase.

2016

9556Background: Melanoma brain metastases (BM) are associated with poor prognosis. Although novel therapies such as ipilimumab (IPI) and anti-PD1 (aPD1: nivolumab and pembrolizumab) have shown thei...

Keywords:

Cohort
Melanoma
Immunotherapy
Pathology
Medicine
national cohort
Pembrolizumab
Oncology
Internal medicine
Ipilimumab
poor prognosis
Nivolumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations